NZ260970A - Treating neoplastic cells by inserting an inactive mutant pem gene into the cells - Google Patents

Treating neoplastic cells by inserting an inactive mutant pem gene into the cells

Info

Publication number
NZ260970A
NZ260970A NZ260970A NZ26097091A NZ260970A NZ 260970 A NZ260970 A NZ 260970A NZ 260970 A NZ260970 A NZ 260970A NZ 26097091 A NZ26097091 A NZ 26097091A NZ 260970 A NZ260970 A NZ 260970A
Authority
NZ
New Zealand
Prior art keywords
cells
inactive mutant
treating neoplastic
pem gene
neoplastic cells
Prior art date
Application number
NZ260970A
Other languages
English (en)
Inventor
Carol L Macleod
Original Assignee
Res Dev Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Dev Foundation filed Critical Res Dev Foundation
Publication of NZ260970A publication Critical patent/NZ260970A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NZ260970A 1990-10-01 1991-09-17 Treating neoplastic cells by inserting an inactive mutant pem gene into the cells NZ260970A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/590,894 US5342761A (en) 1990-10-01 1990-10-01 Oncofetal gene, gene product and uses therefor
NZ239828A NZ239828A (en) 1990-10-01 1991-09-17 Cdna clone obtained from a t-lymphoma library (pem), the protein coded for and their uses

Publications (1)

Publication Number Publication Date
NZ260970A true NZ260970A (en) 1997-08-22

Family

ID=24364171

Family Applications (2)

Application Number Title Priority Date Filing Date
NZ260970A NZ260970A (en) 1990-10-01 1991-09-17 Treating neoplastic cells by inserting an inactive mutant pem gene into the cells
NZ239828A NZ239828A (en) 1990-10-01 1991-09-17 Cdna clone obtained from a t-lymphoma library (pem), the protein coded for and their uses

Family Applications After (1)

Application Number Title Priority Date Filing Date
NZ239828A NZ239828A (en) 1990-10-01 1991-09-17 Cdna clone obtained from a t-lymphoma library (pem), the protein coded for and their uses

Country Status (15)

Country Link
US (1) US5342761A (enFirst)
EP (1) EP0551446A4 (enFirst)
JP (1) JPH06502176A (enFirst)
CN (1) CN1060871A (enFirst)
AU (1) AU665932B2 (enFirst)
CA (1) CA2092916A1 (enFirst)
FI (1) FI931427A7 (enFirst)
IE (1) IE913263A1 (enFirst)
IL (1) IL99496A0 (enFirst)
NO (1) NO931138L (enFirst)
NZ (2) NZ260970A (enFirst)
PT (1) PT99122B (enFirst)
TW (1) TW287198B (enFirst)
WO (1) WO1992006218A1 (enFirst)
ZA (1) ZA917423B (enFirst)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5342761A (en) * 1990-10-01 1994-08-30 Research Development Foundation Oncofetal gene, gene product and uses therefor
US5866329A (en) * 1995-09-27 1999-02-02 Demetriou; Achilles A. Method and probe for detection of gene associated with liver neoplastic disease
DE19855013C2 (de) * 1998-11-20 2001-09-13 Schering Ag Androgen- und Progesteron-Rezeptor bindendes Hormon Response Element
EP1224259A4 (en) * 1999-09-27 2005-04-27 Univ Florida INVERSION OF INSULIN DEPENDENT DIABETES BY ISOLATED STEM CELLS, PROGENITOR ISLANDIC CELLS, AND INSULAR TYPE STRUCTURES
US20030078396A1 (en) * 2000-03-01 2003-04-24 Corixa Corporation Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
US20040005561A1 (en) * 2000-03-01 2004-01-08 Corixa Corporation Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
US20040002068A1 (en) * 2000-03-01 2004-01-01 Corixa Corporation Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
AU4347701A (en) * 2000-03-01 2001-09-12 Corixa Corp Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
CN100355782C (zh) * 2000-05-08 2007-12-19 上海东方肝胆外科医院 新的肝癌高表达基因、其编码的蛋白及其应用
WO2002064828A1 (en) * 2001-02-09 2002-08-22 University College London A method for identifying a target (gene) associated with a disease
US8491883B2 (en) 2003-06-27 2013-07-23 Advanced Technologies And Regenerative Medicine, Llc Treatment of amyotrophic lateral sclerosis using umbilical derived cells
US8790637B2 (en) 2003-06-27 2014-07-29 DePuy Synthes Products, LLC Repair and regeneration of ocular tissue using postpartum-derived cells
US9572840B2 (en) 2003-06-27 2017-02-21 DePuy Synthes Products, Inc. Regeneration and repair of neural tissue using postpartum-derived cells
US7875273B2 (en) 2004-12-23 2011-01-25 Ethicon, Incorporated Treatment of Parkinson's disease and related disorders using postpartum derived cells
US8518390B2 (en) 2003-06-27 2013-08-27 Advanced Technologies And Regenerative Medicine, Llc Treatment of stroke and other acute neural degenerative disorders via intranasal administration of umbilical cord-derived cells
US7875272B2 (en) 2003-06-27 2011-01-25 Ethicon, Incorporated Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells
ES2542069T3 (es) 2003-06-27 2015-07-30 DePuy Synthes Products, Inc. Regeneración y reparación de tejido neural usando células del postparto derivadas del cordón umbilical
US9592258B2 (en) 2003-06-27 2017-03-14 DePuy Synthes Products, Inc. Treatment of neurological injury by administration of human umbilical cord tissue-derived cells
WO2005071066A1 (en) * 2004-01-23 2005-08-04 Board Of Regents, The University Of Texas System Methods and compositions for preparing pancreatic insulin secreting cells
CN1712541B (zh) * 2004-06-25 2012-07-25 中国科学院上海生命科学研究院 肝细胞癌相关的蛋白质分子标记异种核糖核蛋白k的筛选及其应用
EP1831356B1 (en) 2004-12-23 2017-01-25 DePuy Synthes Products, Inc. Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
US9388382B2 (en) * 2005-10-05 2016-07-12 The Board Of Trustees Of The University Of Illinois Isolation of CD14 negative, CD45 positive and CD117 positive embryonic-like stem cells free of monocytes from human umbilical cord blood mononuclear cells
ES2642844T3 (es) 2005-12-16 2017-11-20 DePuy Synthes Products, Inc. Composiciones y métodos para inhibir una respuesta inmune adversa en el trasplante de histocompatibilidad que no coinciden
US8741638B2 (en) * 2005-12-19 2014-06-03 DePuy Synthes Products, LLC In vitro expansion of postpartum-derived cells in roller bottles
US9125906B2 (en) 2005-12-28 2015-09-08 DePuy Synthes Products, Inc. Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
DK2078073T3 (da) 2006-10-12 2013-10-28 Ethicon Inc Nyreafledte celler og fremgangsmåder til anvendelse deraf til vævsreparation og -regenerering
US8835163B2 (en) * 2006-10-18 2014-09-16 The Board Of Trustees Of The University Of Illinois Embryonic-like stem cells derived from adult human peripheral blood and methods of use
US20080182328A1 (en) * 2006-12-19 2008-07-31 The Burnham Institute Mammalian extraembryonic endoderm cells and methods of isolation
AU2008308531B2 (en) 2007-10-05 2014-04-24 Ethicon, Incorporated Repair and regeneration of renal tissue using human umbilical cord tissue-derived cells
US8236538B2 (en) * 2007-12-20 2012-08-07 Advanced Technologies And Regenerative Medicine, Llc Methods for sterilizing materials containing biologically active agents
US10179900B2 (en) * 2008-12-19 2019-01-15 DePuy Synthes Products, Inc. Conditioned media and methods of making a conditioned media
ES2665883T3 (es) 2008-12-19 2018-04-30 DePuy Synthes Products, Inc. Tratamiento de enfermedades y trastornos pulmonares y pulmonares
SG174551A1 (en) 2009-03-26 2011-10-28 Ethicon Inc Human umbilical cord tissue cells as therapy for alzheimer' s disease
US8889413B2 (en) 2009-09-30 2014-11-18 DePuy Synthes Products, LLC Mammary artery derived cells and methods of use in tissue repair and regeneration
US8323972B2 (en) 2009-09-30 2012-12-04 Advanced Technologies And Regenerative Medicine, Llc Mammary artery derived cells and methods of use in tissue repair and regeneration
SG11201403465PA (en) 2011-12-23 2014-10-30 Atrm Llc Detection of human umbilical cord tissue-derived cells

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5342761A (en) * 1990-10-01 1994-08-30 Research Development Foundation Oncofetal gene, gene product and uses therefor

Also Published As

Publication number Publication date
AU8915191A (en) 1992-04-28
EP0551446A1 (en) 1993-07-21
CA2092916A1 (en) 1992-04-02
NZ239828A (en) 1995-04-27
AU665932B2 (en) 1996-01-25
EP0551446A4 (en) 1994-05-18
IE913263A1 (en) 1992-04-08
FI931427L (fi) 1993-04-27
TW287198B (enFirst) 1996-10-01
PT99122B (pt) 1999-03-31
PT99122A (pt) 1992-09-30
FI931427A0 (fi) 1993-03-30
CN1060871A (zh) 1992-05-06
ZA917423B (en) 1992-05-27
US5342761A (en) 1994-08-30
IL99496A0 (en) 1992-08-18
NO931138D0 (no) 1993-03-26
NO931138L (no) 1993-05-10
JPH06502176A (ja) 1994-03-10
WO1992006218A1 (en) 1992-04-16
FI931427A7 (fi) 1993-04-27

Similar Documents

Publication Publication Date Title
NZ260970A (en) Treating neoplastic cells by inserting an inactive mutant pem gene into the cells
GB2251119B (en) Electrochemical cell
GB2244593B (en) Electrochemical cells
EP0649569A4 (en) ELECTROCHEMICAL CELL.
IL87001A0 (en) Haloarylnitrile degrading gene,and cells containing the gene
AU5050193A (en) Sollar cell
AU9087891A (en) Electrochemical cell
AU8632091A (en) Process for introducing foreign dna into cell
GB2243017B (en) Electrochemical cell
GB9105155D0 (en) Electrochemical cell
ZA927752B (en) Electrochemical cell.
GB9011034D0 (en) Electrochemical cell
GB2249659B (en) Electrochemical cell
GB2246904B (en) Electrochemical cell
GB2241108B (en) Electrochemical cell
GB2242306B (en) Electrochemical cell
ZA913608B (en) Electrochemical cell
GB9104820D0 (en) Electrochemical cell
GB2244594B (en) Electrochemical cell
GB9107612D0 (en) Cell culture
IE900091L (en) Electrochemical cells
IL124137A (en) Laser processing chamber with cassette cell
GB9008012D0 (en) Electrochemical cell
GB9008110D0 (en) Electrochemical cell
ZA919814B (en) Electrochemical cell